Facebook Pixel Code

Sandu Pharmaceuticals Share Price

NSE
BSE

SANDU PHARMACEUTICALS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Sandu Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹47.94
-1.74₹ -0.85
As on Sep 18, 2025, 12:38 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Sandu Pharmaceuticals Price Performance

Today's LowToday's High
₹47.00₹49.49
₹47.94
52 Weeks' Low52 Weeks' High
₹43.75₹67.50
₹47.94
Open Price
₹49.49
Prev. Close
₹48.79
Volume
960

Over the last 5 years, the share price of Sandu Pharmaceuticals has gained 15.82% CAGR. Over the past year, the corresponding return has been -25.56%.

Sandu Pharmaceuticals’s current P/E of 29.27x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.

Sandu Pharmaceuticals Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Sandu Pharmaceuticals
0.93-1.86-3.64-5.56-25.56-11.7515.82
Sun Pharmaceutical Industries
1.830.4-0.52-6.27-10.5723.2925.65
Divi's Laboratories
1.04-1.47-7.075.1611.1118.8412.66
Cipla
0.580.364.784.06-4.9614.9114.24
Torrent Pharmaceuticals
-0.66-2.6410.2313.435.8433.9719.87
Dr. Reddy's Laboratories
0.813.970.112.820.0317.034.28
Mankind Pharma
-0.085.0510.2120.888.2522.1412.75
Zydus Lifesciences
-1.364.337.4713.97-4.6441.9720.26
Lupin
2.173.174-0.17-8.6546.8513.36
Abbott India
0.73-4.37-0.974.7112.2521.5213.57
Alkem Laboratories
1.642.5714.1913.95-9.9419.1213.94
Aurobindo Pharma
-0.421.38-0.19-2.83-28.1928.585.93
Glenmark Pharmaceuticals
-2.165.425.3542.7426.577.7432.55
Laurus Labs
0.984.4336.215486.3621.2124.78
Biocon
-0.89-0.995.397.27-0.847.53-4.49
Anthem Biosciences
4.16.6516.9316.9316.935.353.18
GlaxoSmithKline Pharmaceuticals
-4.53-1.99-16.77-2.08-2.1924.669.98
Cohance Lifesciences
-8.31.51-9.35-19.46-20.2925.6618.7
Ipca Laboratories
1.06-4.22-2.66-1.49-8.1815.644.07
Gland Pharma
1.621.3115.2226.328.42-3.821.87

Over the last one year, Sandu Pharmaceuticals has declined 25.56% compared to peers like Sun Pharmaceutical Industries (-10.57%), Divi's Laboratories (11.11%), Cipla (-4.96%). From a 5 year perspective, Sandu Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (25.65%) and Divi's Laboratories (12.66%).

Sandu Pharmaceuticals Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Sandu Pharmaceuticals Stock Technicals

Moving Average

DaySMAEMA
547.5147.9
1047.7947.93
2048.3848.18
5048.8448.88
10050.4449.94
20051.8652

Sandu Pharmaceuticals Share Holding Pattern

In the latest quarter, Sandu Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 0.01%, FII holding unchanged at 0.00%, and public shareholding moved down to 57.08% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Sandu Pharmaceuticals Corporate Actions

Date Time
Announcement
Sep 08, 2025, 8:45 PM ISTSandu Pharmaceut - Announcement Under Regulation 30-Update-Show Cause Notice U/S 9(2) Of The Maharashtra Tax On Professions,
Sep 07, 2025, 10:18 PM ISTSandu Pharmaceut - Newspaper Publication Post Dispatch Notice Of Annual General Meeting And Evoting Instructions
Sep 06, 2025, 10:11 PM ISTSandu Pharmaceut - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Re
Sep 06, 2025, 10:04 PM ISTSandu Pharmaceut - Notice Of The 40Th Annual General Meeting Of Sandu Pharmaceuticals Limited To Be Held On 30Th September 2
Sep 06, 2025, 10:01 PM ISTSandu Pharmaceut - Reg. 34 (1) Annual Report.

About Sandu Pharmaceuticals

Sandu Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/11/1985 and has its registered office in the State of Goa, India. Company's Corporate Identification Number(CIN) is L24233GA1985PLC001587 and registration number is 001587. Currently Company is involved in the business activities of Manufacture of `ayurvedic' or `unani' pharmaceutical preparation. Company's Total Operating Revenue is Rs. 67.19 Cr. and Equity Capital is Rs. 9.66 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Umesh B Sandu
    Executive Director
  • Mr. Shashank B Sandu
    Non Exe.Non Ind.Director
  • Dr.(Mrs.) Shubhada P Sandu
    Non Exe.Non Ind.Director
  • Mr. Ajit R Kantak
    Ind. Non-Executive Director
  • Mr. Balram Viswanathan
    Ind. Non-Executive Director

FAQs on Sandu Pharmaceuticals Share Price

What is the share price of Sandu Pharmaceuticals?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Sandu Pharmaceuticals is ₹47.94 as on Sep 18, 2025.

What kind of stock is Sandu Pharmaceuticals?

The Sandu Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Sandu Pharmaceuticals?

The market cap of Sandu Pharmaceuticals is ₹45.41 Cr as on Sep 18, 2025.

What are today's High and Low prices of Sandu Pharmaceuticals?

Today’s highest and lowest price of Sandu Pharmaceuticals are ₹49.49 and ₹47.00.

What are the 52 Week High and 52 Week Low of Sandu Pharmaceuticals?

The 52-week high/low is the highest and lowest price at which Sandu Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Sandu Pharmaceuticals is ₹67.50 and 52-week low of Sandu Pharmaceuticals is ₹43.75 as on Sep 18, 2025.

How has the Sandu Pharmaceuticals performed historically in terms of returns?

The Sandu Pharmaceuticals has shown returns of -1.74% over the past day, -1.86% for the past month, -3.64% over 3 months, -25.56% over 1 year, -11.75% across 3 years, and 15.82% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Sandu Pharmaceuticals?

P/E ratio of and PB ratio of Sandu Pharmaceuticals are 29.27 and 1.11 on Sep 18, 2025. While the company gives a dividend yield of 1.70 per annum.

icon
Market Data